Evan Ingley
Impact in
- Molecular Biology top 5%
- PI3K/AKT/mTOR signaling in cancer
- Protein Kinase Regulation and GTPase Signaling
- Ubiquitin and proteasome pathways
- Immunology top 5%
- Immune Cell Function and Interaction
Papers in
-
- Protein Kinase Regulation and GTPase Signaling 10
- Signaling Pathways in Disease 5
- Glycosylation and Glycoproteins Research 4
- Oncology 21
- Cytokine Signaling Pathways and Interactions 19
- Co-authors
- Brian A. Hemmings (6 shared papers)Matthias Frech (2 shared papers)Mirjana Andjelković (2 shared papers)S. Peter Klinken (12 shared papers)K. Kishta Reddy (1 shared paper)John R. Falck (1 shared paper)S. Peter Klinken (13 shared papers)Peta A. Tilbrook (13 shared papers)
- Journals
- Journal of Biological Chemistry (11 papers)Blood (6 papers)Oncogene (5 papers)Biochemical Journal (3 papers)IUBMB Life (2 papers)
- Partner nations
- AustraliaUnited StatesSwitzerland
In The Last Decade
Evan Ingley
65 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 99
- Molecular Biology 1.4k
- Immunology 416
- Cell Biology 330
- Genetics 198
- Hematology 210
Countries citing papers authored by Evan Ingley
This map shows the geographic impact of Evan Ingley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evan Ingley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evan Ingley more than expected).
Fields of papers citing papers by Evan Ingley
This network shows the impact of papers produced by Evan Ingley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evan Ingley. The network helps show where Evan Ingley may publish in the future.
Co-authors
The 25 scholars most cited alongside Evan Ingley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 366 | |
| 2 | 2007 | 266 | |
| 3 | 2001 | 207 | |
| 4 | 2012 | 135 | |
| 5 | 1999 | 100 | |
| 6 | 1999 | 72 | |
| 7 | 1994 | 63 | |
| 8 | 2008 | 57 | |
| 9 | 2002 | 45 | |
| 10 | 1991 | 45 | |
| 11 | Maturation of erythroid cells and erythroleukemia development are affected by the kinase activity of Lyn. | 2001 | 45 |
| 12 | 2004 | 42 | |
| 13 | 2004 | 42 | |
| 14 | 2008 | 39 | |
| 15 | 2006 | 39 | |
| 16 | 2005 | 39 | |
| 17 | 2006 | 38 | |
| 18 | 2000 | 38 | |
| 19 | 2004 | 34 | |
| 20 | 2016 | 29 |
About Evan Ingley
Evan Ingley is a scholar working on Molecular Biology, Oncology, Physiology, Immunology and Genetics, having authored 66 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (19 papers), Erythrocyte Function and Pathophysiology (13 papers), Protein Kinase Regulation and GTPase Signaling (10 papers), Immune Cell Function and Interaction (6 papers), Signaling Pathways in Disease (5 papers), Glycosylation and Glycoproteins Research (4 papers), Cellular transport and secretion (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). The work is most often cited by research in Molecular Biology (1.4k citations), Immunology (416 citations), Cell Biology (330 citations), Genetics (198 citations) and Hematology (210 citations). Evan Ingley has collaborated with scholars based in Australia, United States and Switzerland. Frequent co-authors include Brian A. Hemmings, Matthias Frech, Mirjana Andjelković, S. Peter Klinken, K. Kishta Reddy, John R. Falck, S. Peter Klinken, Peta A. Tilbrook, Ivana Galetić and Derek P. Brazil. Their work appears in journals such as Journal of Biological Chemistry, Blood, Oncogene, Biochemical Journal and IUBMB Life.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.